Stratos Wealth Partners LTD. boosted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 19.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,076 shares of the company’s stock after purchasing an additional 824 shares during the period. Stratos Wealth Partners LTD.’s holdings in GE HealthCare Technologies were worth $397,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Mesirow Financial Investment Management Inc. grew its holdings in GE HealthCare Technologies by 39.6% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company’s stock valued at $383,000 after purchasing an additional 1,159 shares in the last quarter. Cathy Pareto & Associates Inc. acquired a new position in GE HealthCare Technologies during the 4th quarter worth $670,000. LMR Partners LLP acquired a new position in GE HealthCare Technologies during the 3rd quarter worth $7,387,000. Principal Financial Group Inc. grew its holdings in GE HealthCare Technologies by 1.9% during the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock worth $94,780,000 after acquiring an additional 19,010 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG acquired a new position in GE HealthCare Technologies during the 3rd quarter worth $1,396,000. 82.06% of the stock is owned by institutional investors and hedge funds.
GE HealthCare Technologies Stock Performance
Shares of GEHC opened at $85.90 on Thursday. The company’s 50 day moving average price is $83.58 and its 200 day moving average price is $85.39. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.55. The company has a market capitalization of $39.25 billion, a PE ratio of 23.60, a PEG ratio of 2.93 and a beta of 1.15. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23.
GE HealthCare Technologies Increases Dividend
Wall Street Analysts Forecast Growth
GEHC has been the subject of several research reports. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company lifted their price target on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $96.77.
Get Our Latest Report on GE HealthCare Technologies
GE HealthCare Technologies Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Recommended Stories
- Five stocks we like better than GE HealthCare Technologies
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Stock Market Sectors: What Are They and How Many Are There?
- Inflation Persists, But So Do Stock Opportunities: Rally On
- 10 Best Airline Stocks to Buy
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.